Evolving Concepts in Cardiac Physiologic Pacing in the Era of Conduction System Pacing.

Cardiac physiologic pacing (CPP) has become a well-established therapy for patients with cardiomyopathy (left ventricular ejection fraction <35%) in the presence of a left bundle branch block. In addition, CPP can be highly beneficial in patients with pacing-induced cardiomyopathy and patients with existing cardiomyopathy expected to have a right ventricular pacing burden of >40%. The benefits of CPP with traditional biventricular pacing are only realized if adequate resynchronization can be achieved. However, left ventricular lead implantation can be limited by individual anatomic variation within the coronary venous system and can be adversely affected by underlying abnormal myocardial substrate (i.e., scar tissue), especially if located within the basal lateral wall. In the last 7 years the investigation of conduction system pacing (CSP) and its potential salutary benefits are being realized and have led to a rapid evolution in the field of cardiac resynchronization pacing. However, supportive evidence for CSP for patients eligible for cardiac resynchronization remains limited compared with data available for biventricular cardiac resynchronization, mostly derived from leading CSP investigative centers. In this review, we perform an up-to-date comprehensive review of the available literature on CPP.

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Sharma has been a speaker for Medtronic and a consultant for Abbott, Boston Scientific, and Biotronik. Dr. Huang has received speaker honoraria from Biotronik. Dr. Trohman reports serving as an advisor to Boston Scientific, receiving grants from Boston Scientific, Medtronic, and Abbott; serving as a consultant for Abbott; and receiving speaker fees from Boston Scientific, Medtronic, and Abbott. The remaining authors have no competing interests to declare.